I

Inselspital | Universitatsklinik Inselspital Bern - Gastroenterologie

Research site

(Unclaimed)

Location

freiburgstrasse 18, Bern, Bern, Switzerland

Site insights

Top conditions

Top treatments

Atezolizumab

Gemcitabine

Pregabalin

Diroximel Fumarate

GDC-6036

Avonex

Sonidegib

Dimethyl Fumarate

Ibrutinib

Androgen

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 24 total trials

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation

This is a Phase I dose-escalation and dose-expansion study that will evaluate the safety, pharmacokinetics (PK), and preliminary activity of GDC-6036...

Enrolling

Advanced Solid Tumors

Colorectal Cancer

Drug: Inavolisib

Drug: Atezolizumab

Atezolizumab After Concurrent Chemo-radiotherapy Versus Chemo-radiotherapy Alone in Limited Disease Small-cell Lung Cancer (ACHILES)

Some patients with limited disease small-cell lung cancer (LD SCLC) are cured after chemo-radiotherapy, but the majority relapse and die from their c...

Active, not recruiting

Small-cell Lung Cancer

Drug: Atezolizumab

Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes (REVITALIZE 1)

The Revita® system is being investigated to assess the efficacy of DMR versus Sham on improvement in Glycemic, Hepatic and Cardiovascular endpoints f...

Enrolling

Type 2 Diabetes

Device: Duodenal Mucosal Resurfacing (Sham)

Device: Duodenal Mucosal Resurfacing (DMR)